Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009
Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]
DRUGS APPROVED BY THE FDA FOR WEIGHT LOSS
DRUGS APPROVED BY THE FDA FOR WEIGHT LOSS
Drugs approved for use in weight loss programs can be broken
down into the following categories:
1. Anorexiants (drugs that work on chemicals in the brain)
a. Amphetamines
1. Benzphetamine (Didrex®)
2. Diethylpriopion (Tenuate®; Tenuate Dospan®)
3. Methamphetamine (Desoxyn®)
4. Phentermine (Adipex®; Adipex®-P or Ionamin®)
b. Sibutramine (Meridia®)
2. Lipase Inhibitors (drugs [...]
How Diet Pills Work
How Diet Pills Work
In the quest for the perfect diet pill, scientists, doctors, and those who are going to use these drugs need to understand how diet pills work. Knowing what actions a drug takes and how it affects the body helps scientists and doctors understand what side effects the [...]
Roche, GlaxoSmithKline Sign Promotional Agreement for Xenical in U.S.
Pharmaceutical giants Roche and GlaxoSmithKline have signed a promotional agreement for weight-loss medication Xenical (orlistat) in the United States, according to a statement issued April 12th.
The pact gives Glaxo exclusive rights to promote prescription Xenical in the United States. Glaxo also acquired the rights to an over-the-counter (OTC) version of the [...]
Europeans to Decide Whether to Further Restrict Diet Drug Acomplia This Week
Will diet drug Acomplia (rimonabant), taken this past year by more than 100,000 Europeans seeking to lose weight, be pulled from the European market out of concern over depressive and suicidal side-effects?
That decision will be made known July 19th following this week’s safety review by the European [...]
FDA Approves New Diet Drug, But Not Acomplia or Alli (and Also Not for Humans)
For all those awaiting Food and Drug Administation action on a new diet drug, the on Jan. 5th approved one — but it was not highly anticipated Acomplia (rimonabant) and not Alli (the long-awaited over-the-counter version of Xenical).
In fact, it is not a diet drug [...]
A year ago at this time, millions of overweight and obese Americans were excitedly awaiting both a new prescription weight-loss drug, rimonabant (Acomplia / Zimulti) , and the first over-the-counter diet drug, Alli (low-dose Xenical), which were expected to be on the U.S. market by summer. [...]
Diet Drug Acomplia Sales Dwarfed by Initial Sales of Diet Pill alli
Just how badly sales of diet drug Acomplia (rimonabant) have been set back by Sanofi’s inability to bring it to the U.S. market was dramatically illustrated July 25th when GlaxoSmithKline revealed initial launch results for over-the-counter diet pill alli (low-dose Xenical).
Sales of non-prescription alli totaled a [...]
